Therapeutics MD | 8-K: FY2025 Q3 Revenue: USD 784 K

DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

DaVita Inc. (DVA) shares rose 1.09% to $123.60 on Wednesday, amid a generally positive market, with the S&P 500 up 0.06% and the Dow Jones up 0.68%. Despite this gain, DaVita's stock remains 31.18% below its 52-week high of $179.60. Compared to competitors, DaVita underperformed as UnitedHealth Group rose 3.55%, while Icon PLC was unchanged and Quest Diagnostics fell 1.06%. Trading volume for DaVita was 919,621, surpassing its 50-day average of 831,289.

Coty Inc. Cl A Stock Underperforms Monday When Compared To Competitors

Coty Inc. Cl A (COTY) shares fell 5.33% to $3.55 on a positive trading day for the market, with the S&P 500 up 1.54% and the Dow Jones up 0.81%. The stock is 55.85% below its 52-week high of $8.04. Compared to competitors, Estee Lauder rose 2.14%, while Interparfums fell 0.39%. Trading volume was 11.4 million, above the 50-day average of 6.4 million.

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

TherapeuticsMD Inc. (TXMD) shares rose 1.71% to $1.19 on a strong trading day, outperforming competitors like AbbVie Inc. (ABBV), which increased by 0.41%. This marks the second consecutive day of gains for TXMD, although it remains 51.23% below its 52-week high of $2.44. The NASDAQ Composite Index and Dow Jones Industrial Average also saw increases of 0.65% and 0.48%, respectively. Trading volume was below the 50-day average.

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

TherapeuticsMD Inc. (TXMD) shares rose 1.74% to $1.17 on Tuesday, breaking a two-day losing streak, despite a poor overall market performance with the NASDAQ down 2.04%. The stock remains 52.05% below its 52-week high of $2.44. In comparison, competitor AbbVie Inc. (ABBV) saw a 1.85% increase. Trading volume for TXMD was significantly below its 50-day average.